Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells

Infection and Immunity

Volumn 74, Issue 1, 2006, Pages 152-159

  Hassan, Ghada S ^a   Mukherjee, Shankar ^a   Nagajyothi, Fnu ^a   Weiss, Louis M ^a   Petkova, Stefka B ^a,d   De Almeida, Cecilia J ^a   Huang, Huan ^a   Desruisseaux, Mahalia S ^a   Bouzahzah, Boumediene ^a   Pestell, Richard G ^b   Albanese, Chris ^b   Christ, George J ^c   Lisanti, Michael P ^a   Tanowitz, Herbert B ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CAVEOLIN 1; CAVEOLIN 3; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLINE; DNA; ENDOTHELIN A RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN; PREPROENDOTHELIN 1; RETINOBLASTOMA PROTEIN; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CAROTID ARTERY; CELL CULTURE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; CULTIVATED LAND; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE; UMBILICAL VEIN; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; BROMODEOXYURIDINE; CAROTID ARTERIES; CAVEOLINS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CHAGAS DISEASE; CYCLIN D1; ENDOTHELIAL CELLS; ENDOTHELIN-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MALE; MICE; MICE, INBRED A; MICE, INBRED C3H; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, ENDOTHELIN A; RNA PRECURSORS; TRYPANOSOMA CRUZI;

EID: 29644445685     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.1.152-159.2006     Document Type: Article

References (46)

1. Brink, P. R., S. V. Ramanan, and G. G. Christ. 1996. Human connexin 43 gap junction channel gating: evidence for mode shifts and/or heterogeneity. Am. J. Physiol. 271:C321-C331.
2. 2+ in cultured human corporal smooth muscle cells. Am. J. Physiol. 263:C373-C383.
3. Cohen, A. W., D. S. Park, S. E. Woodman, T. M. Williams, M. Chandra, J. Shirani, A. P. de Souza, R. N. Kitsis, R. G. Russell, L. M. Weiss, B. Tang, L. A. Jelicks, S. M. Factor, V. Shtutin, H. B. Tanowitz, and M. P. Lisanti. 2003. Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 284:C457-C474.
4. Consolim-Colombo, F. M., H. F. Lopes, E. A. Rosetto, E. C. Rubira, J. A. S. Barreto-Filho, A. C. A. Baruzzi, N. N. Rocha, C. Mady, M. C. Irigoyen, and E. M. Krieger. 2004. Endothelial function is preserved in Chagas' heart disease patients without heart failure. Endothelium 11:241-246.
5. Couet, J., M. Sargiacomo, and M. P. Lisanti. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272:30429-30438.
6. B receptor in cardiovascular physiology and pathophysiology. Pharmacol. Ther. 95:221-238.
7. Engelman, J. A., C. Chu, A. Lin, H. Jo, T. Ikezu, T. Okamotod, D. S. Kohtz, and M. P. Lisanti. 1998. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428:205-211.
8. Engelman, J. A., C. C. Wycoff, S. Yasuharai, K. S. Song, T. Okamoto, and M. P. Lisanti. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272:16374-16381.
9. Galbiati, F., D. Volonte, J. A. Engelman, G. Watanabe, R. Burk, R. G. Pestell, and M. P. Lisanti. 1998. Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17:6633-6648.
10. Galie, N., A. Manes, and A. Branzi. 2004. The endothelin system in pulmonary arterial hypertension. Cardiovasc. Res. 61:227-337.
11. Hassan, G. S., J.-F. Jasmin, W. Schubert, P. G. Frank, and M. P. Lisanti. 2004. Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 43:8312-8321.
12. Hou, Y. Z., J. Yang, G.-R. Zhao, and Y.-J. Yuan. 2004. Ferulic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II. Eur. J. Pharmacol. 499:85-90.
13. Huang, H., T. M. Calderon, J. W. Berman, V. L. Braunstein, L. M. Weiss, M. Wittner, and H. B. Tanowitz. 1999. Infection of endothelial cells with Trypansoma cruzi activates NF-κB and induces vascular adhesion molecule expression, Infect. Immun. 67:5434-5440.
14. Huang, H., S. B. Petkova, A. W. Cohen, B. Bouzahzah, J. Chan, J.-N. Zhou, S. M. Factor, L. M. Weiss, M. Krishnamachary, S. Mukherjee, M. Wittner, R. N. Kitsis, R. G. Pestell, M. P. Lisanti, C. Albanese, and H. B. Tanowitz. 2003. Activation of transcription factors (AP-1 and NF-κB) in murine chagasic myocarditis. Infect. Immun. 71:2859-2867.
15. Hulit, J., T. Bash, M. Fu, F. Galbiati, C. Albanese, D. R. Sage, A. Schlegel, J. Zhurinsky, M. Shtutman, A. Ben-Ze'ev, M. P. Lisanti, and R. G. Pestell. 2000. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J. Biol. Chem. 275:21203-21209.
16. Jelicks, L. A., M. Chandra, J. Shirani, V. Shtutin, B. Tang, G. J. Christ, S. M. Factor, M. Wittner, H. Huang, L. M. Weiss, S. Mukherjee, B. Bouzahzah, S. B. Petkova, M. M. Teixeira, S. A. Douglas, M. L. Loredo, P. D'Orleans-Juste, and H. B. Tanowitz. 2002. Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int. J. Parasitol. 32:1497-1506.
17. Kedzierski, R. M., and M. Yanagisawa. 2001. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41:851-876.
18. Kim, H. S., H. J. Cho, H.-J. Cho, S.-J. Park, K.-W. Park, I.-H. Chae, B.-H. Oh, Y.-B. Park, and M.-M. Lee. 2004. The essential role of p21 in radiation-induced cell cycle arrest of vascular smooth muscle cell. J. Mol. Cell. Cardiol. 37:871-880.
19. Kitagawa, M., H. Higashi, H. K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya. 1996. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060-7069.
20. Leon, J. S., and D. M. Engman. 2003. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front. Biosci. 8:e315-e322.
21. Masaki, T. 1998. The discovery of endothelins. Cardiovasc. Res. 39:530-533.
22. Montes de Oca, M., S. H. Torres, J. G. Loyo, F. Vasquez, N. Hernandez, B. Anchustegui, and J. J. Puigbo. 2004. Exercise performance and skeletal muscles in patients with advanced Chagas disease. Chest 125:1306-1324.
23. Morris, S. A., H. B. Tanowitz, M. Wittner, and J. P. Bilezikian. 1990. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 82:1900-1999.
24. Morris, S. A., L. M. Weiss, S. M. Factor, J. P. Bilezikian, H. B. Tanowitz, and M. Wittner. 1989. Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice. J. Am. Coll. Cardiol. 14:782-789.
25. Mukherjee, S., H. Huang, S. B. Petkova, C. Albanese, R. G. Pestell, V. L. Braunstein, G. J. Christ, M. Wittner, M. P. Lisanti, J. W. Berman, L. M. Weiss, and H. B. Tanowitz. 2004. Tiypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect. Immun. 72:5274-5282.
26. Park, D. S., H. Lee, P. G. Frank, B. Razani, A. V. Nguyen, A. F. Parlow, R. G. Russell, J. Hulit, R. G. Pestell, and M. P. Lisantiet. 2002. Caveotin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Mol. Biol. Cell 13:3416-3430.
27. Petkova, S. B., A. Ashton, B. Bouzahzah, H. Huang, R. G. Pestell, and H. B. Tanowitz. 2000. Cell cycle molecules and diseases of the cardiovascular system. Front. Biosci. 5:D452-D460.
28. Petkova, S. B., H. Huang, S. M. Factor, R. G. Pestell, B. Bouzahzah, L. A. Jelicks, L. M. Weiss, S. A. Douglas, M. Wittner, and H. B. Tanowitz. 2001. The role of endothelin in the pathogenesis of Chagas' disease. Int. J. Parasitol. 31:499-511.
29. Petkova, S. B., H. B. Tanowitz, H. I. Magazine, S. M. Factor, J. Chan, R. G. Pestell, B. Bouzahzah, S. A. Douglas, V. Shtutin, S. A. Morris, E. Tsang, L. M. Weiss, G. J. Christ, M. Wittner, and H. Huang. 2000. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc. Pathol. 9:257-265.
30. Rossi, M. A. 1990. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am. Heart J. 120:233-236.
31. Rossi, M. A., and S. G. Ramos. 1996. Coronary microvascular abnormalities in Chagas' disease. Am. Heart J. 132:207-210.
32. Rowin, K. S., H. B. Tanowitz, M. Wittner, H. T. Nyguen, and B. Nadal-Ginard. 1983. Inhibition of muscle differentiation by Trypanosoma cruzi. Proc. Natl. Acad. Sci. USA 80:6390-6394.
33. 1 phase progression. Genes Dev. 13:1501-1512.
34. Tanowitz, H. B., E. R. Burns, A. K. Sinha, N. N. Kahn, S. A. Morris, S. M. Factor, V. B. Hatcher, J. P. Bilezikian, and M. Wittner. 1990. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am. J. Trop. Med. Hyg. 43:274-281.
35. Tanowitz, H. B., J. P. Gumprecht, D. Spurr, T. M. Calderon, M. C. Ventura, C. Raventos-Suarez, S. M. Factor, V. Hatcher, M. Wittner, and J. W. Berman. 1992. Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J. Infect. Dis. 166:598-603.
36. Tanowitz, H. B., H. Huang, L. A. Jelicks, M. Chandra, M. L. Loredo, L. M. Weiss, S. M. Factor, V. Shtutin, S. Mukherjee, R. N. Kitsis, G. J. Christ, M. Wittner, J. Shirani, Y. Y. Kisanuki, and M. Yanagisawa. 2005. Role of endothelin-1 in the pathogenesis of chronic chagasic heart disease. Infect. Immun. 73:2496-2503.
37. Tanowitz, H. B., D. K. Kaul, B. Chen, S. A. Morris, S. M. Factor, L. M. Weiss, and M. Wittner. 1996. Compromised microcirculation in acute Trypanosoma cruzi infection. J. Parasitol. 82:124-130.
38. Tanowitz, H. B., L. V. Kirchhoff, D. Simon, S. A. Morris, L. M. Weiss, and M. Wittner. 1992. Chagas' disease. Clin. Microbiol. Rev. 4:400-419.
39. Tanowitz, H. B., S. A. Morris, S. M. Factor, L. M. Weiss, and M. Wittner. 1992. Parasitic disease of the heart I: acute and chronic Chagas' disease. Cardiovasc. Pathol. 1:7-15.
40. Tanowitz, H. B., M. Wittner, B. Chen, H. Huang, L. M. Weiss, G. J. Christ, V. L. Braunstein, J. P. Bilezikian, and S. A. Morris. 1996. Effects of verapamil on acute Chagas' disease. J. Parasitol. 82:814-819.
41. Tarleton, R. L. 2001. Parasite persistence in the aetiology of Chagas disease. Int. J. Parasitol. 31:550-554.
42. Torres, F. W., H. Acqualella, J. A. Condado, R. Dinsmore, and I. F. Palacios. 1995. Coronary reactivity is abnormal with Chagas' disease. Am. Heart J. 129:995-1001.
43. Torres, S. H., H. J. Finol, M. Montes de Oca, F. Vasquez, J. J. Puigbo, and J. G. Loyo. 2004. Capillary damage in skeletal muscle in advanced Chagas' disease patients. Parasitol. Res. 93:364-368.
44. Wittner, M., G. J. Christ, H. Huang, L. M. Weiss, V. B. Hatcher, S. A. Morris, G. A. Orr, J. W. Berman, G. A. Zeballos, S. A. Douglas, and H. B. Tanowitz. 1995. Trypanosoma cruzi induces endothelin release from endothelial cells. J. Infect. Dis. 171:493-497.
45. Zabalgoittia, M., J., Ventura, J. Lozano, L. Anderson, K. Carey, G. Hubbard, J. Williams, and J. Vandeberg. 2004. Myocardial contrast echocardiography in assessing microcirculation in baboons with Chagas disease. Microcirculation 11:271-278.
46. Zhao, W., and G. J. Christ. 1995. Endothelin-1 as a putative modulator of erectile dyfunction. II. Calcium mobilization in cultured human corporal smooth muscle cells. J. Urol. 154:1571-1577.